Anzupgo (delgocitinib) is the first and only topical medication specifically approved for adults with moderate to severe chronic hand eczema. In large clinical trials, the cream significantly improved ...

Chronic hand eczema is a type of skin disease that affects the skin on your hands and wrists. While there is no cure for chronic hand eczema, different types of medicines can be used to help manage ...

A first-in-class topical pan-Janus kinase (JAK) inhibitor significantly improved symptoms of moderate to severe chronic hand eczema in two randomized phase III trials. At week 16, more patients ...

Please provide your email address to receive an email when new articles are posted on . In two phase 3 trials, delgocitinib cream improved hand eczema in a greater proportion of patients vs. vehicle.

Add Yahoo as a preferred source to see more of our stories on Google. Basic tasks can be a pain in the you-know-what when arthritis is part of your life. The aching, the swelling, the joint pain — who ...

San Diego — Data from an open-label extension study of delgocitinib cream reflects the positive phase 3 safety and efficacy results released > 1 year ago from two separate trials in patients with ...

Chronic hand eczema (CHE) is a condition separate from eczema, also known as atopic dermatitis, and has a prevalence rate of approximately 4.7% MADISON, N.J.--(BUSINESS WIRE)--Ninety-five percent (95% ...

If a person hides their own hand and focuses on a rubber hand instead, they may perceive it as part of their own body under certain conditions. What sounds like a gimmick could one day be used to help ...

The newly FDA-approved treatment Anzupgo (delgocitinib) could offer steroid-free relief for people living with intensely dry, itchy, painful skin. Anzupgo (delgocitinib) is the first and only topical ...